| 1997 |
CAML acts as a signaling intermediate downstream of TACI (a TNF receptor superfamily member). Cross-linking of TACI activated NF-AT, AP-1, and NF-κB transcription factors, and a dominant-negative CAML mutant specifically blocked TACI-induced NF-AT activation, placing CAML in the TACI signaling pathway. |
Dominant-negative mutant transfection, transcriptional reporter assays, antibody cross-linking in Jurkat T cells |
Science |
Medium |
9311921
|
| 2003 |
CAML is required for recycling of internalized EGF receptor (EGFR) back to the plasma membrane. CAML-deficient cells show normal EGFR internalization and EGF-induced signaling but defective receptor recycling and reduced surface EGFR accumulation. CAML directly associates with the kinase domain of EGFR in a ligand-dependent manner. |
CAML gene knockout (mouse embryonic fibroblasts), EGF receptor trafficking assays (surface accumulation, internalization, recycling), co-immunoprecipitation |
Developmental Cell |
High |
12919676
|
| 2005 |
CAML interacts with ATRAP (AT1 receptor-associated protein) via its N-terminal hydrophilic domain (aa 1–189) and functions as a signal transducer for angiotensin II-mediated NFAT activation. ATRAP overexpression decreased CAML/Ang II-induced NFAT activation, while ATRAP knockdown increased NFAT activity; the CAML N-terminal domain (aa 1–189) sensitized NFAT activation in response to Ang II. The CAML–ATRAP interaction localizes to ER vesicular structures. |
Yeast two-hybrid, co-immunoprecipitation, bioluminescence resonance energy transfer (BRET), immunofluorescence colocalization, RNA interference, transcriptional reporter assays in HEK293 cells |
Journal of Biological Chemistry |
High |
15668245
|
| 2005 |
CAML interacts with p56Lck and regulates its subcellular localization in resting and TCR-stimulated thymocytes. CAML-deficient thymocytes show enhanced p56Lck and ZAP-70 phosphorylation and increased IL-2 production and cell death after TCR stimulation, indicating CAML acts as a negative regulator of p56Lck signaling. CAML is essential for positive selection and suppression of negative selection during thymopoiesis. |
Conditional CAML knockout in mouse thymocytes, co-immunoprecipitation, kinase phosphorylation assays, IL-2 production assays, flow cytometry of thymocyte populations |
Immunity |
High |
16111633
|
| 2005 |
The intracellular C-terminus of fibrocystin (ARPKD protein) directly interacts with CAML. Both proteins co-localize in the apical membrane, primary cilia, and basal body of distal nephron cells. |
Yeast two-hybrid screen, co-immunoprecipitation from COS7 cells, immunofluorescence colocalization |
Biochemical and Biophysical Research Communications |
Low |
16243292
|
| 2009 |
CAML loss causes anaphase failure and chromosome missegregation. CAML-deficient MEFs fail to segregate chromosomes in anaphase (a 'cut' phenotype), have spindle dysfunction, lagging/misaligned chromosomes and chromatin bridges, a modestly weakened spindle assembly checkpoint (SAC), and increased aneuploidy. CAML functions as a regulator of mitotic spindle function and a modulator of SAC maintenance. |
Cre-loxP conditional knockout MEFs, live-cell imaging, spindle assembly checkpoint assays, aneuploidy measurement by cytogenetics |
Cell Cycle |
High |
19229138
|
| 2010 |
CAML-deficient thymocytes accumulate high levels of reactive oxygen species (ROS) and undergo accelerated apoptosis. Genetic removal of the pro-apoptotic BH3-only protein Bim (but not deletion of p53 or Fas) significantly rescued survival of CAML-deficient thymocytes, placing CAML upstream of Bim-dependent apoptosis in thymocyte survival. |
Conditional knockout, genetic epistasis (CAML KO × Bim KO double mutant mice), ROS measurement, in vitro apoptosis assays |
Cell Death and Differentiation |
High |
20300112
|
| 2010 |
CAML interacts with TMUB1 (C7orf21/HOPS). The interaction was identified by yeast two-hybrid screen of a brain library and confirmed by co-immunoprecipitation in HEK cells. Both proteins co-localize in the cytoplasm. |
Yeast two-hybrid, co-immunoprecipitation in HEK cells, immunofluorescence colocalization |
PloS One |
Low |
20582322
|
| 2010 |
CAML does not contribute to tetherin-mediated restriction of HIV-1 particle release. Stable depletion of CAML in HeLa cells had no effect on cell-surface tetherin levels and did not relieve tetherin-mediated restriction. |
Stable shRNA knockdown of CAML, flow cytometry for tetherin surface levels, HIV particle release assays |
PloS One |
Medium |
20126395
|
| 2010 |
CAML is required for prolactin receptor (PRLR) signaling. CAML associates with PRLR and this interaction is augmented by PRL stimulation. CAML silencing impairs PRLR-dependent Stat5 and Mek1/2 activation, PRL internalization with cyclophilin B, PRLR recycling, and Ca2+ mobilization, thereby reducing PRL-dependent proliferation of breast cancer cells. |
Co-immunoprecipitation, siRNA silencing, signaling pathway assays (Stat5, Mek1/2 phosphorylation), Ca2+ measurement, receptor recycling assays |
Breast Cancer Research and Treatment |
Medium |
21128111
|
| 2012 |
CAML is essential for survival of peripheral follicular (Fo) B cells. Conditional deletion of CAML in B cells caused reduced Fo B cell numbers, increased cellular turnover, and increased apoptosis after LPS and IL-4 stimulation, establishing an ongoing anti-apoptotic role for CAML in mature B cells. |
Conditional B cell-specific CAML knockout (CD19-Cre), flow cytometry, in vitro apoptosis assays, inducible gene deletion in mature B cells |
Journal of Immunology |
High |
22351938
|
| 2014 |
WRB and CAML together form a functional receptor complex for TRC40 (Get3) at the ER membrane and are both necessary and sufficient for tail-anchored (TA) protein targeting and insertion into the ER. The transmembrane segments of CAML are essential for creating a functional receptor with WRB. Binding parameters of TRC40 to the WRB/CAML receptor were determined. Yeast lacking GET1 and GET2 are functionally complemented by WRB and CAML. |
Yeast complementation assay (GET1/GET2 deletion complementation), in vivo TA protein targeting assays, binding affinity measurement (TRC40 to WRB/CAML), domain mutagenesis of CAML transmembrane segments |
PloS One |
High |
24392163
|
| 2017 |
CAML supports survival and mitotic progression in Myc-driven B-cell lymphomas independently of its TA protein insertion function. The C-terminal 111 amino acid region of CAML (encompassing the WRB-binding domain but not the TRC40-interaction domain) was sufficient to rescue survival and growth of CAML-deleted lymphoma cells without restoring TA protein insertion. Cell death was blocked by Bcl-2/Bcl-xL overexpression. Loss of CAML caused G2/M arrest with low phospho-histone H3. |
Tamoxifen-inducible conditional knockout in Eμ-Myc lymphoma cells, domain deletion/rescue experiments, cell cycle analysis, Bcl-2/Bcl-xL overexpression rescue, in vivo tumor regression assay |
Cell Death Discovery |
High |
28580168
|
| 2018 |
CAML interacts with TMUB1 via TMUB1's TM1 hydrophobic domain. TMUB1 overexpression abolishes the interaction between CAML and its downstream binding partner cyclophilin B, thereby reducing intracellular Ca2+ ([Ca2+]i) and inhibiting hepatocyte proliferation. CAML–cyclophilin B interaction acts upstream of calcineurin to regulate Ca2+ signaling during proliferation. |
Co-immunoprecipitation in BRL-3A rat hepatocytes, Ca2+ influx measurement, TMUB1 overexpression and knockout, TM1 domain deletion mutant |
Scientific Reports |
Medium |
29967478
|
| 2018 |
Classical Swine Fever Virus p7 interacts with CAMLG at the ER membrane, and this interaction is required for p7-mediated calcium permeability at the ER. Mutant p7 forms unable to interact with CAMLG failed to mediate calcium permeability and showed decreased virulence. |
Yeast two-hybrid, confocal colocalization in eukaryotic cells with p7 mutants, calcium permeability assays in ER |
Viruses |
Medium |
30154321
|
| 2019 |
WRB is required for the correct topological integration of CAML into the ER membrane. Without sufficient WRB, CAML fails to adopt its correct three-transmembrane-segment topology and instead generates two aberrant topoforms that congregate in ER-associated clusters and are degraded by the proteasome. WRB acts catalytically to assist CAML topogenesis, consistent with WRB being a member of the Oxa1 superfamily. |
Topology mapping (CAML topology determination), WRB knockdown/depletion, proteasome inhibitor treatment, immunofluorescence of aberrant CAML clusters, cell fractionation |
Scientific Reports |
High |
31417168
|
| 2022 |
Loss of functional CAML (via homozygous splice variant c.633+4A>G) causes mislocalization of syntaxin-5 and drastic reduction of Bet1L (v-SNARE) in patient fibroblasts and siCAMLG-depleted HeLa cells, indicating CAML (as part of the TRC pathway) is required for proper assembly of Golgi SNARE complexes and correct TA protein insertion. This CAML deficiency causes a congenital disorder of glycosylation (combined O-linked and type II N-linked glycosylation defect). |
Patient fibroblast analysis (homozygous splice variant), siRNA knockdown in HeLa cells, Western blot and immunofluorescence of syntaxin-5 and Bet1L, glycosylation biochemical analysis |
Human Molecular Genetics |
High |
35262690
|
| 2025 |
CAML is required for motor neuron survival and neuromuscular function via its role in the TRC pathway for TA protein insertion. Neuron-specific CAML deletion causes hind limb weakness, paralysis, and loss of spinal motor neuron cell bodies. CAML depletion perturbs intracellular trafficking: aberrant procathepsin D release, defective CD222 retention in the trans-Golgi network, reduced and mislocalized syntaxin-5, dysfunctional lysosomes, and abnormal protein glycosylation. Neuronal deletion of ASNA1 (TRC40/GET3) produces an identical phenotype, confirming the mechanistic link to the TRC pathway. |
Neuron-specific conditional knockout (SLICK-H-Cre and synapsin-Cre), global hypomorphic CAML mice, histology of spinal cord, intracellular trafficking assays (procathepsin D secretion, CD222 localization, syntaxin-5 localization), glycosylation analysis, ASNA1 neuronal KO genetic epistasis |
PLoS Genetics |
High |
39823474
|